{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:24:05Z","timestamp":1761845045569},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Renal osteodystrophy (ROD) occurs as early as chronic kidney disease (CKD) stage 2 and seems ubiquitous in almost all pediatric patients with CKD stage 5. Fibroblast growth factor (FGF)-23, a bone-derived endocrine regulator of phosphate homeostasis, is overexpressed in CKD and disturbs osteoblast differentiation and matrix mineralization. In contrast, C-type natriuretic peptide (CNP) acts as a potent positive regulator of bone growth. In the present study, we infused CNP into uremic rats and observed whether CNP could attenuate ROD through the inhibition of FGF-23 cascades. In uremic rats, CNP administration significantly alleviated renal dysfunction, calcium phosphate metabolic disorders, hypovitaminosis D, secondary hyperparathyroidism, the decrease in bone turnover markers and retarded bone pathological progression. More importantly, within FGF-23\/mitogen-activated protein kinase (MAPK) signaling, the fibroblast growth factor receptor-1, Klotho and alternative (STAT-1\/phospho-STAT-1) elements were upregulated by CNP, whereas FGF-23, RAF-1\/phospho-RAF-1, and downstream (ERK\/phospho-ERK and P38\/phospho-P38) elements were paradoxically underexpressed in bone tissue. Therefore, CNP exerts a therapeutic effect on ROD through inhibition of FGF-23\/MAPK signaling at the RAF-1 level.<\/jats:p>","DOI":"10.1038\/s12276-019-0265-8","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T10:03:09Z","timestamp":1561975389000},"page":"1-18","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["C-type natriuretic peptide attenuates renal osteodystrophy through inhibition of FGF-23\/MAPK signaling"],"prefix":"10.1038","volume":"51","author":[{"given":"Dong Dong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huang Huang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang Mei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"265_CR1","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2215\/CJN.06200614","volume":"10","author":"M Bonthuis","year":"2015","unstructured":"Bonthuis, M. et al. Mineral metabolism in European children living with a renal transplant: a European society for pediatric nephrology\/european renal association-European dialysis and transplant association registry study. Clin. J. Am. Soc. Nephrol. 10, 767\u2013775 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"265_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","volume":"55","author":"K Uhlig","year":"2010","unstructured":"Uhlig, K. et al. KDOQI US commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of CKD-mineral and bone disorder (CKD-MBD). Am. J. Kidney Dis. 55, 773\u2013799 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"265_CR3","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2215\/CJN.05940611","volume":"7","author":"K Wesseling-Perry","year":"2012","unstructured":"Wesseling-Perry, K. et al. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin. J. Am. Soc. Nephrol. 7, 146\u2013152 (2012).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"265_CR4","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/CIA.S41132","volume":"8","author":"NT Chang","year":"2013","unstructured":"Chang, N. T. et al. Epidemiological study of orthopedic injuries in hemodialysis patients in Taiwan: a fixed cohort survey, 2004-2008. Clin. Interv. Aging 8, 301\u2013308 (2013).","journal-title":"Clin. Interv. Aging"},{"key":"265_CR5","first-page":"83","volume":"25","author":"GB Spasovski","year":"2004","unstructured":"Spasovski, G. B. Bone biopsy in the diagnosis of renal osteodystrophy. Prilozi 25, 83\u201393 (2004).","journal-title":"Prilozi"},{"key":"265_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142924","volume":"10","author":"AA Portale","year":"2015","unstructured":"Portale, A. A. et al. Characterization of FGF23-dependent egr-1 cistrome in the mouse renal proximal tubule. PLoS One 10, e0142924 (2015).","journal-title":"PLoS One"},{"key":"265_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada, T. et al. FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J. Bone Miner. Res. 19, 429\u2013435 (2004).","journal-title":"J. Bone Miner. Res."},{"key":"265_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7150\/ijbs.3886","volume":"8","author":"P Hu","year":"2012","unstructured":"Hu, P. et al. Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of Vitamin D in chronic kidney disease. Int. J. Biol. Sci. 8, 663\u2013671 (2012).","journal-title":"Int. J. Biol. Sci."},{"key":"265_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","volume":"23","author":"D Sitara","year":"2004","unstructured":"Sitara, D. et al. Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol. 23, 421\u2013432 (2004).","journal-title":"Matrix Biol."},{"key":"265_CR10","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1359\/jbmr.080220","volume":"23","author":"H Wang","year":"2008","unstructured":"Wang, H. et al. Over-expression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J. Bone Miner. Res. 23, 939\u2013948 (2008).","journal-title":"J. Bone Miner. Res."},{"key":"265_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1002427","volume":"14","author":"SK Murali","year":"2016","unstructured":"Murali, S. K., Andrukhova, O., Clinkenbeard, E. L., White, K. E. & Erben, R. G. Excessive osteocytic fgf23 secretion contributes to pyrophosphate accumulation and mineralization defect in Hyp mice. PLoS Biol. 14, e1002427 (2016).","journal-title":"PLoS Biol."},{"key":"265_CR12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ajpath.2010.10.006","volume":"178","author":"A Pai","year":"2011","unstructured":"Pai, A., Leaf, E. M., El-Abbadi, M. & Giachelli, C. M. Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease. Am. J. Pathol. 178, 764\u2013773 (2011).","journal-title":"Am. J. Pathol."},{"key":"265_CR13","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez, O. et al. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J. Am. Soc. Nephrol. 16, 2205\u20132215 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"265_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/0006-291X(90)92401-K","volume":"168","author":"T Sudoh","year":"1990","unstructured":"Sudoh, T., Minamino, N., Kangawa, K. & Matsuo, H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun. 168, 863\u2013870 (1990).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"265_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1042\/CS20090092","volume":"118","author":"PR Kalra","year":"2009","unstructured":"Kalra, P. R. et al. C-type natriuretic peptide production by the human kidney is blunted in chronic heart failure. Clin. Sci. 118, 71\u201377 (2009).","journal-title":"Clin. Sci."},{"key":"265_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-7-87","volume":"7","author":"H Agoston","year":"2006","unstructured":"Agoston, H., Baybayan, L. & Beier, F. Dexamethasone stimulates expression of C-type natriuretic peptide in chondrocytes. BMC Musculoskelet. Disord. 7, 87 (2006).","journal-title":"BMC Musculoskelet. Disord."},{"key":"265_CR17","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1111\/j.1742-4658.2011.08082.x","volume":"278","author":"LR Potter","year":"2011","unstructured":"Potter, L. R. Natriuretic peptide metabolism, clearance and degradation. FEBS J. 278, 1808\u20131817 (2011).","journal-title":"FEBS J."},{"key":"265_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00223-001-1012-3","volume":"70","author":"A Inoue","year":"2002","unstructured":"Inoue, A., Kobayashi, Y., Ishizuka, M., Hirose, S. & Hagiwara, H. Identification of a novel osteoblastic gene, inducible by C-type natriuretic peptide, whose transcript might function in mineralization as a noncoding RNA. Calcif. Tissue Int. 70, 111\u2013116 (2002).","journal-title":"Calcif. Tissue Int."},{"key":"265_CR19","doi-asserted-by":"publisher","first-page":"C1311","DOI":"10.1152\/ajpcell.1996.270.5.C1311","volume":"270","author":"H Hagiwara","year":"1996","unstructured":"Hagiwara, H. et al. cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells. Am. J. Physiol. 270, C1311\u2013C1318 (1996).","journal-title":"Am. J. Physiol."},{"key":"265_CR20","doi-asserted-by":"publisher","first-page":"11385","DOI":"10.1074\/jbc.M115.704015","volume":"291","author":"DM Dickey","year":"2016","unstructured":"Dickey, D. M. et al. Catalytically active guanylyl cyclase B requires endoplasmic reticulum-mediated glycosylation, and mutations that inhibit this process cause dwarfism. J. Biol. Chem. 291, 11385\u201311393 (2016).","journal-title":"J. Biol. Chem."},{"key":"265_CR21","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1210\/en.2010-0078","volume":"151","author":"T Fujii","year":"2010","unstructured":"Fujii, T. et al. Circulating C-type natriuretic peptide (CNP) rescues chondrodysplastic CNP knockout mice from their impaired skeletal growth and early death. Endocrinology 151, 4381\u20134388 (2010).","journal-title":"Endocrinology"},{"key":"265_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.peptides.2012.06.009","volume":"37","author":"P Hu","year":"2012","unstructured":"Hu, P. et al. Increased urinary C-type natriuretic peptide excretion may be an early marker of renal tubulointerstitial fibrosis. Peptides 37, 98\u2013105 (2012).","journal-title":"Peptides"},{"key":"265_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/labinvest.2014.149","volume":"95","author":"P Hu","year":"2015","unstructured":"Hu, P. et al. Exogenous C-type natriuretic peptide infusion ameliorates unilateral ureteral obstruction-induced tubulointerstitial fibrosis in rats. Lab. Invest. 95, 263\u2013272 (2015).","journal-title":"Lab. Invest."},{"key":"265_CR24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C (T) method. Nat. Protoc. 3, 1101\u20131108 (2008).","journal-title":"Nat. Protoc."},{"key":"265_CR25","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00467-009-1166-1","volume":"24","author":"YH Qin","year":"2009","unstructured":"Qin, Y. H. et al. Effect of all-trans retinoic acid on renal expressions of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rats with glomerulosclerosis. Pediatr. Nephrol. 24, 1477\u20131486 (2009).","journal-title":"Pediatr. Nephrol."},{"key":"265_CR26","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1681\/ASN.2006020130","volume":"17","author":"J Li","year":"2006","unstructured":"Li, J., Deane, J. A., Campanalem, N. V., Bertram, J. F. & Ricardo, S. D. Blockade of p38 mitogen-activated protein kinase and TGF-beta 1\/S mad signaling pathways cues bone marrow-derived peritubular capillary endothelial cells in adriamycin-induced nephrosis. J. Am. Soc. Nephrol. 17, 2799\u20132811 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"265_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD update Work Group.","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD update Work Group. KDIGO 2017 Clinical Practice Guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease\u2013mineral and bone disorder (CKD-MBD). Kidney Int Suppl. (2011) 7, 1\u201359 (2017).","journal-title":"Kidney Int Suppl. (2011)"},{"key":"265_CR28","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.1093\/ndt\/gfs138","volume":"27","author":"P Marckmann","year":"2012","unstructured":"Marckmann, P. et al. Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D. Nephrol. Dial. Transpl. 27, 3523\u20133531 (2012).","journal-title":"Nephrol. Dial. Transpl."},{"key":"265_CR29","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1046\/j.1523-1755.2000.00306.x","volume":"58","author":"ML Picton","year":"2000","unstructured":"Picton, M. L. et al. Down-regulation of human osteoblast PTH\/PTHrP receptor mRNA in end-stage renal failure. Kidney Int. 58, 1440\u20131449 (2000).","journal-title":"Kidney Int."},{"key":"265_CR30","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1210\/jc.2012-4188","volume":"98","author":"MR Denburg","year":"2013","unstructured":"Denburg, M. R. et al. Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J. Clin. Endocrinol. Metab. 98, 1930\u20131938 (2013).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"265_CR31","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1038\/ki.2011.27","volume":"79121","author":"H Ju\u00a8ppner","year":"2011","unstructured":"Ju\u00a8ppner, H. Phosphate and FGF-23. Kidney Int. 79121, S24\u201372011 (2011).","journal-title":"Kidney Int."},{"key":"265_CR32","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/ki.2010.313","volume":"78","author":"H Hasegawa","year":"2010","unstructured":"Hasegawa, H. et al. Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int. 78, 975\u2013980 (2010).","journal-title":"Kidney Int."},{"key":"265_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191706","volume":"13","author":"H Sugiura","year":"2018","unstructured":"Sugiura, H. et al. Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model. PLoS ONE 13, e0191706 (2018).","journal-title":"PLoS ONE"},{"key":"265_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S8756-3282(99)00263-X","volume":"26","author":"H Ishii","year":"2000","unstructured":"Ishii, H. et al. Daily intermittent decreases in serum levels of parathyroid hormone have an anabolic-like action on the bones of uremic rats with low-turnover bone and osteomalacia. Bone 26, 175\u2013182 (2000).","journal-title":"Bone"},{"key":"265_CR35","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1053\/j.ajkd.2015.06.023","volume":"67","author":"SM Sprague","year":"2016","unstructured":"Sprague, S. M. et al. Diagnostic accuracy of bone turnover markers and bone histology in patients with CKD treated by dialysis. Am. J. Kidney Dis. 67, 559\u2013566 (2016).","journal-title":"Am. J. Kidney Dis."},{"key":"265_CR36","first-page":"1462","volume":"41","author":"JF Van Vleet","year":"1980","unstructured":"Van Vleet, J. F. & Ferrans, V. J. Clinical and pathologic features of chronic adriamycin toxicosis in rabbits. Am. J. Vet. Res. 41, 1462\u20131469 (1980).","journal-title":"Am. J. Vet. Res."},{"key":"265_CR37","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.kint.2016.12.029","volume":"91","author":"FG Graciolli","year":"2017","unstructured":"Graciolli, F. G. et al. The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease. Kidney Int. 91, 1436\u20131446 (2017).","journal-title":"Kidney Int."},{"key":"265_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0133278","volume":"10","author":"HW Liao","year":"2015","unstructured":"Liao, H. W. et al. Relationship between Fibroblast Growth Factor 23 and biochemical and bone histomorphometric alterations in a chronic kidney disease rat model undergoing parathyroidectomy. PLoS ONE 10, e0133278 (2015).","journal-title":"PLoS ONE"},{"key":"265_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/8756-3282(89)90002-1","volume":"10","author":"JF Staub","year":"1989","unstructured":"Staub, J. F., Tracqui, P., Lausson, S., Milhaud, G. & Perault-Staub, A. M. A physiological view of in vivo calcium dynamics: the regulation of a nonlinear self-organized system. Bone 10, 77\u201386 (1989).","journal-title":"Bone"},{"key":"265_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/cbin.10573","volume":"40","author":"J Teerapornpuntakit","year":"2016","unstructured":"Teerapornpuntakit, J., Wongdee, K., Krishnamra, N. & Charoenphandhu, N. Expression of osteoclastogenic factor transcripts in osteoblast-like UMR-106 cells after exposure to FGF-23 or FGF-23 combined with parathyroid hormone. Cell Biol. Int. 40, 329\u2013340 (2016).","journal-title":"Cell Biol. Int."},{"key":"265_CR41","first-page":"405","volume":"68","author":"A Lenz","year":"2010","unstructured":"Lenz, A., Bennett, M., Skelton, W. P. & Vesely, D. L. Vessel dilator and C-type natriuretic peptide enhance the proliferation of human osteoblasts. Pediatr. Res. 68, 405\u2013408 (2010).","journal-title":"Pediatr. Res."},{"key":"265_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1093\/ndt\/gft456","volume":"29","author":"A Bouma-de Krijger","year":"2014","unstructured":"Bouma-de Krijger, A. et al. Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease. Nephrol. Dial. Transpl. 29, 88\u201397 (2014).","journal-title":"Nephrol. Dial. Transpl."},{"key":"265_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113482","volume":"10","author":"A Doyon","year":"2015","unstructured":"Doyon, A. et al. Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease. PLoS ONE 10, e0113482 (2015).","journal-title":"PLoS ONE"},{"key":"265_CR44","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/ki.2013.271","volume":"85","author":"Y Fang","year":"2014","unstructured":"Fang, Y. et al. Early chronic kidney disease-mineral bone disorder stimulates vascular calcification. Kidney Int. 85, 142\u2013150 (2014).","journal-title":"Kidney Int."},{"key":"265_CR45","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3109\/10799893.2015.1075041","volume":"36","author":"P Hu","year":"2016","unstructured":"Hu, P. et al. Therapeutic effect of CNP on renal osteodystrophy by antagonizing the FGF-23\/MAPK pathway. J. Recept. Signal Transduct. Res. 36, 213\u2013219 (2016).","journal-title":"J. Recept. Signal Transduct. Res."},{"key":"265_CR46","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ki.2009.414","volume":"77","author":"H Komaba","year":"2010","unstructured":"Komaba, H. et al. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int. 77, 232\u2013238 (2010).","journal-title":"Kidney Int."},{"key":"265_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00223-011-9501-5","volume":"89","author":"V Shalhoub","year":"2011","unstructured":"Shalhoub, V. et al. Fibroblast growth factor 23 (FGF23) and alpha-klotho stimulate osteoblastic MC3T3.E1 cell proliferation and inhibit mineralization. Calcif. Tissue Int. 89, 140\u2013150 (2011).","journal-title":"Calcif. Tissue Int."},{"key":"265_CR48","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/jbmr.401","volume":"26","author":"D Ranch","year":"2011","unstructured":"Ranch, D., Zhang, M. Y., Portale, A. A. & Perwad, F. Fibroblast growth factor 23 regulates renal 1, 25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice. J. Bone Miner. Res. 26, 1883\u20131890 (2011).","journal-title":"J. Bone Miner. Res."},{"key":"265_CR49","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.kint.2016.01.024","volume":"90","author":"N Carrillo-L\u00f3pez","year":"2016","unstructured":"Carrillo-L\u00f3pez, N. et al. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease. Kidney Int. 90, 77\u201389 (2016).","journal-title":"Kidney Int."},{"key":"265_CR50","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1172\/JCI116800","volume":"92","author":"CM Wei","year":"1993","unstructured":"Wei, C. M., Kim, C. H. & Miller, V. M. Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide. J. Clin. Invest. 92, 2048\u20132052 (1993).","journal-title":"J. Clin. Invest."},{"key":"265_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.toxicon.2013.07.016","volume":"74","author":"RS Alves","year":"2013","unstructured":"Alves, R. S. et al. Isolation, homology modeling and renal effects of a C-type natriuretic peptide from the venom of the Brazilian yellow scorpion (Tityus serrulatus). Toxicon 74, 19\u201326 (2013).","journal-title":"Toxicon"},{"key":"265_CR52","doi-asserted-by":"publisher","first-page":"5089","DOI":"10.1242\/jcs.02618","volume":"118","author":"P Krejci","year":"2005","unstructured":"Krejci, P. et al. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J. Cell Sci. 118, 5089\u20135100 (2005).","journal-title":"J. Cell Sci."},{"key":"265_CR53","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1101\/gad.13.11.1361","volume":"13","author":"M Sahni","year":"1999","unstructured":"Sahni, M. et al. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev. 13, 1361\u20131366 (1999).","journal-title":"Genes Dev."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0265-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0265-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T14:07:47Z","timestamp":1650463667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-019-0265-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["265"],"URL":"https:\/\/doi.org\/10.1038\/s12276-019-0265-8","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"21 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}